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1  | INTRODUC TION
Over	the	past	few	years,	the	transplant	community	has	made	great	
efforts	 to	 increase	 the	 pediatric	 priority	 in	 liver	 organ	 allocation;	
however,	the	mortality	of	children	candidates	for	 liver	transplanta‐
tion	(LT),	who	are	disadvantaged	because	of	the	lack	of	size‐matched	
donors,	 has	 been	 steady	 at	 approximately	 10%	every	 year.1,2 Split 
liver	 transplantation	 (SLT)	 was	 introduced	 to	 expand	 the	 pool	 of	
grafts	available	for	pediatric	recipients,	providing	a	 left	 lateral	seg‐
ment	(LLS)	to	a	child	and	an	extended‐right	graft	 (ERG)	to	an	adult	
recipient.3	After	the	initial	splitting	experience,	advances	in	surgical	
techniques	and	a	better	understanding	of	recipient/donor	matching	
led	to	excellent	SLT	outcomes	both	in	pediatric	and	adult	recipients.4‐9
Different	organ	allocation	systems	encouraged	the	implementa‐
tion	of	SLT	to	expand	the	graft	availability	from	deceased	donors	for	
children,	without	disadvantaging	adult	LT	candidates.10	The	SLT	rate	
varies	worldwide:	in	Europe,	SLT	represents	approximately	6%	of	all	
LT.11	In	the	United	States,	SLT	comprises	approximately	1%	of	all	LT,	
despite	the	fact	that	it	is	estimated	that	20%	of	deceased	donors	meet	
United	Network	of	Organ	Sharing	(UNOS)	guidelines	for	split	livers.12 
In	Italy,	after	the	encouraging	results	of	the	initial	SLT	experience	of	
the	North	 Italian	Transplant	programme,13	since	2015	the	National	
Transplantation	Centre	(CNT)	in	collaboration	with	the	Italian	College	
of	Liver	Transplantation	Programmes	defined	a	mandatory‐split	liver	
policy	(SLP)	in	order	to	increase	the	number	of	splitting	procedures	
nationwide	and	to	reduce	pediatric	LT‐waiting	list	mortality.
This	 study	aims	 to	analyze	 liver	allocation	 in	 Italy	after	 the	 in‐
troduction	of	the	new	SLP	and	its	impact	on	the	pediatric/adult	LT‐ 
waiting	list	and	on	SLT	outcomes.
2  | MATERIAL S AND METHODS
2.1 | Liver allocation policy in Italy
In	Italy	there	are	21	LT	centers	divided	into	13	regions	governed	by	the	
CNT	network	and	grouped	into	two	macro‐areas	 (Figure	1).	Since	the	
CNT's	establishment,	liver	allocation	policies	have	seen	several	modifi‐
cations.	The	first	national	SLT	allocation	program	was	approved	in	2006;	
transplant	centers	could	voluntary	decide	whether	or	not	to	participate.	
At	 that	 time,	 donors	 aged	 ≤14	years	were	 preferentially	 allocated	 to	
pediatric	 recipients	 (<18	years),	 whereas	 donors	 ≥15	years	were	 allo‐
cated	to	adults.	Donors	aged	10‐50	years	with	stable	hemodynamics,	
intensive	therapy	unit	(ITU)‐stay	≤5	days,	transaminases	≤3	times	nor‐
mal,	and	absence	of	steatosis	on	the	ultrasound	scan	were	defined	as	
“splittable.”	The	decision	of	whether	or	not	to	perform	the	splitting	pro‐
cedure	was	the	choice	of	the	LT	center	to	which	the	graft	was	assigned.
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To	 implement	 split	 liver	 transplantation	 (SLT)	 a	 mandatory‐split	 policy	 has	 been	
adopted	in	Italy	since	August	2015:	donors	aged	18‐50	years	at	standard	risk	are	of‐
fered	 for	SLT,	 resulting	 in	a	 left‐lateral	 segment	 (LLS)	graft	 for	children	and	an	ex‐
tended‐right	 graft	 (ERG)	 for	 adults.	 We	 aim	 to	 analyze	 the	 impact	 of	 the	 new	
mandatory‐split	 policy	on	 liver	 transplantation	 (LT)‐waiting	 list	 and	SLT	outcomes,	
compared	to	old	allocation	policy.	Between	August	2015	and	December	2016	out	of	
413	potentially	 “splittable”	donors,	252	 (61%)	were	proposed	for	SLT,	of	whom	53	
(21%)	donors	were	accepted	for	SLT	whereas	101	(40.1%)	were	excluded	because	of	
donor	characteristics	and	98	(38.9%)	for	absence	of	suitable	pediatric	recipients.	The	
SLT	rate	augmented	from	6%	to	8.4%.	Children	undergoing	SLT	increased	from	49.3%	
to	65.8%	(P	=	.009)	and	the	pediatric	LT‐waiting	list	time	dropped	(229	[10‐2121]	vs	
80	[12‐2503]	days	[P	=	.045]).	The	pediatric	(4.5%	vs	2.5%	[P	=	.398])	and	adult	(9.7%	
to	5.2%	[P	<	.001])	LT‐waiting	list	mortality	reduced;	SLT	outcomes	remained	stable.	
Retransplantation	 (HR	=	2.641,	P	=	.035)	 and	 recipient	weight	 >20	kg	 (HR	=	5.113,	
P	=	.048)	in	LLS,	and	ischemic	time	>8	hours	(HR	=	2.475,	P	=	.048)	in	ERG	were	iden‐
tified	as	predictors	of	graft	failure.	A	national	mandatory‐split	policy	maximizes	the	
SLT	donor	resources,	whose	selection	criteria	can	be	safely	expanded,	providing	fa‐
vorable	 impact	 on	 the	 pediatric	 LT‐waiting	 list	 and	 priority	 for	 adult	 sick	 LT	
candidates.
K E Y W O R D S
clinical	research/practice,	donors	and	donation,	health	services	and	outcomes	research,	liver	
transplantation/hepatology,	liver	transplantation:	split,	organ	allocation,	organ	procurement	
and	allocation,	pediatrics,	waitlist	management
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In	2015,	a	consensus	redefined	the	Italian	criteria	for	LT	candi‐
date	stratification	not	only	based	on	urgency	but	also	on	the	prin‐
ciples	of	utility	and	 transplant	benefit.	The	current	 liver	allocation	
system	is	based	on	the	Model	for	End‐Stage	Liver	Disease	(MELD)/
Italian	 Score	 for	 Organ	 Allocation	 (ISO),	 which	 is	 defined	 by	 bio‐
chemical	MELD	and	exceptions.14	At	present,	liver	grafts	are	shared	
according	 to	 the	 following	principles:	 (1)	nationwide,	 for	 (a)	UNOS	
status	1	patients;	(b)	pediatric	candidates	according	to	the	pediatric	
LT	allocation	system15;	(2)	macro‐areas	for	adult	LT	candidates	with	
MELD	≥30;	and	 (3)	 regionally	 for	adult	patients	with	MELD	<30.14 
Additionally,	the	age	of	the	donors	preferentially	assigned	to	pedi‐
atric	 recipients	 increased	from	14	to	17	years	and	a	national	man‐
datory	SLP	was	adopted.	In	the	new	SLP,	all	deceased	donors	aged	
18‐50	years	with	standard	risk	(defined	as	the	absence	of	potential	
transmissible	 infections	or	neoplastic	diseases)	are	mandatorily	of‐
fered	to	pediatric	transplant	centers	according	to	the	pediatric	na‐
tional	LT‐waiting	 list15	unless	a	UNOS	1	status	or	MELD	≥30	adult	
candidate	is	on	the	waiting	list.	If	the	deceased	donor	is	“splittable,”	
the	LLS	graft	 is	allocated	to	a	pediatric	recipient.	According	to	the	
adult	rules,	the	ERG	is	then	allocated	to	a	recipient	not	only	on	the	
basis	of	the	MELD/ISO	score14	but	also	taking	into	account	clinical	
parameters	and	donor‐to‐recipient	size	matching	(Figure	2).
2.2 | Study design
This	 study	 analyzed	 all	 deceased	donors	 used	 in	 Italy	 for	 LT	 after	
the	introduction	of	the	new	SLP	and	all	recipients	transplanted	with	
LLSs	 and	 ERGs	 derived	 from	 split	 procedures.	 For	 the	 outcome	
analysis,	the	same	number	of	SLTs	performed	consecutively	before	
the	 introduction	 of	 the	 new	 SLP	was	 used	 as	 a	 control	 group.	 To	
evaluate	the	 impact	of	 the	new	SLP,	data	from	adult	and	pediatric	
LT‐waiting	lists	as	well	as	data	on	living	donor	liver	transplantation	
(LDLT)	 activity	 were	 considered.	 Organ	 allocation,	 donor,	 recipi‐
ent,	 and	 surgical	 data	 were	 recovered	 from	 the	 CNT	 prospective	
F I G U R E  1   Italian	adult	and	pediatric	liver	transplant	centers.	In	Italy	there	are	21	LT	centers	divided	into	13	regions	governed	by	the	
National	Transplantation	Centre	network	and	grouped	into	two	macro‐areas	(north	macro‐area	and	south	macro‐area).	Pediatric	LTs	are	
performed	in	5	centers,	of	which	one	center	performs	only	pediatric	transplantation	(Bambino	Gesù	Children's	Hospital	IRCCS	of	Rome)	and	
4	centers	routinely	perform	adult	and	pediatric	LT	(Riuniti	Hospital	of	Bergamo,	University	of	Padua,	Molinette	Hospital	of	Turin,	Istituto	
Mediterraneo	per	i	Trapianti	e	Terapie	ad	Alta	Specializzazione	of	Palermo).	LT,	liver	transplantation
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databases	and	retrospectively	analyzed.	To	define	the	impact	of	the	
split	liver	procuring	centers,	the	pediatric	centers,	which	performed	
all	split	procedures,	were	stratified	according	to	the	number	of	split	
procurements	performed/year	 (high‐volume,	≥15	procedures;	 low‐ 
volume,	<15	procedures).
2.3 | Splitting technique
Since	the	beginning	of	the	Italian	SLT	experience	dating	back	to	the	
mid‐1990s,	split	 liver	has	been	performed	in	situ	by	a	surgical	team	
composed	of	a	pediatric	and	an	adult	transplant	surgeon.	Ex	situ	split	
is	carried	out	only	if	the	in	situ	procedure	might	compromise	the	re‐
covery	of	other	organs	(ie,	donor	hemodynamic	instability)	or	for	in‐
traoperative	technical	issues,	which	did	not	allow	the	in	situ	technique.
Before	 2015,	 parenchymal	 transection	 was	 preferentially	 per‐
formed	using	the	transumbilical	technique16	and	the	celiac	tripod	was	
kept	in	continuity	with	the	left	hepatic	artery.	According	to	the	new	
SLP,	parenchymal	transection	(transumbilical	or	transhilar17) and ves‐
sels’	division	are	decided	in	agreement	between	pediatric	and	adult	
surgeons	 intraoperatively.	The	celiac	 tripod	can	be	assigned	either	
to	the	LLS	or	the	ERG	according	to	(1)	donor‐to‐recipient	size	match‐
ing,	(2)	donors’	vascular	anatomy	(vessels’	sizes,	number	of	branches,	
F I G U R E  2  The	new	Italian	liver	allocation	policy.	The	current	Italian	allocation	policy	stems	from	a	revision	done	in	2015	and	liver	grafts	
are	shared	according	to	the	following	principles:	(1)	nationwide,	for	(a)	UNOS	status	1	patients	(longest	waiting	first);	(b)	pediatric	candidates	
according	to	the	pediatric	LT	allocation	system;	(2)	macro‐areas	for	adult	LT	candidates	with	MELD	scores	≥30	(longest	waiting	first);	and	(3)	
regionally	for	adult	patients	with	MELD	scores	<30	according	to	the	“Italian	Score	for	Organ	Allocation	(ISO).”	In	the	new	split	liver	policy,	
all	deceased	donors	between	18	and	50	years	of	age	with	standard	risk	(defined	as	the	absence	of	potential	transmissible	infections	or	
neoplastic	diseases)	are	mandatorily	offered	to	pediatric	LT	candidates	as	left	lateral	segment	(LLS)	unless	a	UNOS	status	1	patient	or	MELD	
≥30	adult	candidate	is	on	the	waiting	list.	If	the	deceased	donor	is	“splittable,”	the	LLS	is	allocated	to	a	pediatric	recipient	according	to	the	
pediatric	national	waiting	list,	and	the	ERG	is	allocated	to	the	adult	LT	candidate	following	the	regional	and	macro‐area	organ	allocation.	
If	the	deceased	donor	is	defined	as	“not	splittable,”	the	organ	is	used	for	whole	graft	LT	in	adult	recipients	according	to	the	regional	organ	
allocation	system.	ERG,	extended	right	graft;	LLS,	left‐lateral	segment;	LT,	liver	transplantation;	MELD,	Model	for	End‐Stage	Liver	Disease;	
UNOS	United	Network	of	Organ	Sharing;	WLG,	whole	liver	graft
Adult donor ( 18 years) 
Adult recipient with 
MELD 30? Allocation as WLG* 
Donor aged 18-50 years with Allocation as WLG 
Donor offered to Pediatric LT 
candidates as split liver graft
splittable
suitable for Pediatric 
LT candidates 
splittable
Pediatric LT candidate 
LLS graft allocated to Pediatric LT 
candidate 
ERG allocated to adult LT candidate according to 
regional and macro-area organ allocation 
Pediatric donor (<18 years) 
Donor accepted for Pediatric 
LT candidates* 
Donor offered to Pediatric LT candidates 
Donor not accepted for 
Pediatric LT candidates  
Yes 
No 
No 
Yes 
*The assigned transplant center may decide to split or not the graft, in
that case the LLS is offered to Pediatric LT candidates
       Nationwide organ allocation 
        Macro-area organ allocation 
        Regional organ allocation 
Recipient with Status UNOS 1?
Yes 
Allocation as WLG* 
No 
Donor age? 
Liver donor
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segment	IV	branches’	origin),	and	(3)	recipients’	vascular	anatomy	and	
clinical	status	(urgency,	retransplantation,	hepatic	artery	thrombosis).	
The	main	portal	vein	is	assigned	to	the	ERG	and	the	left	portal	vein	
to	the	LLS.	Only	in	case	of	disagreement	regarding	vessels’	division,	
the	final	decision	 is	 taken	by	the	adult	center	 for	donor	≥18	years,	
whereas	by	the	pediatric	centers	for	donor	<18	years.	Intraoperative	
cholangiography	is	not	routinely	performed.
2.4 | Statistical analysis
Statistical	analyses	were	performed	using	IBM	SPSS	Statistics,	ver‐
sion	 22.0	 (IBM,	 Chicago,	 IL).	 Donor/recipient	 characteristics	 and	
clinical	data	are	shown	(wherever	applicable)	as	either	median	with	
range	or	mean	±	standard	deviation.	Univariate	data	were	analyzed	
using	the	Mann‐Whitney	test	and	Fisher's	exact	test.	A	P	value	of	
<.05	 was	 considered	 significant.	 Normal	 distribution	 continuous	
data	 were	 analyzed	 by	 parametric	 test	 (Student's	 t	 test).	 Survival	
rates	were	calculated	using	the	Kaplan‐Meier	method	for	univariate	
analysis	and	Cox‐regression	for	multivariate	analysis.
3  | RESULTS
3.1 | Liver allocation and split liver procurement
Between	August	2015	and	December	2016,	1537	cadaveric	donors	
were	used	 for	LT,	 including	58	 (3.8%)	pediatric	donors	 (<18	years),	
1066	 (69.4%)	 adults	 >50	years	 and/or	 nonstandard	 risk,	 and	 413	
(26.8%)	 adults	 aged	 18‐50	years	 with	 standard	 risk.	 In	 the	 latter	
group,	161	(39%)	donors	were	allocated	to	UNOS	status	1	or	MELD	
≥30	 patients;	 the	 remaining	 252	 (61%)	were	 proposed	 for	 SLT,	 of	
whom	53	(21%)	were	accepted.	One	hundred	and	one	(40.1%)	were	
excluded	 from	 split	 because	 of	 the	 clinical	 characteristics	 of	 the	
donor	at	 the	 time	of	offer	 (n	=	85)	or	at	 laparotomy	 (n	=	16).	 In	88	
cases	 (34.9%),	 the	split	procedure	was	not	performed	 for	absence	
of	suitable	pediatric	 recipient,	and	 in	10	cases	 (4%)	due	 to	 logistic	
issues	 (Table	1).	All	donors	refused	for	SLT	were	allocated	to	adult	
recipients	as	a	whole	graft.	The	donors	accepted	for	SLT	were	sig‐
nificantly	younger,	had	lower	body	weights,	and	received	less	vaso‐
pressor	compared	to	those	not	split	(Table	2).
In	 the	 pediatric	 donor	 group	 (n	=	58),	 45	 (78%)	 livers	 were	
transplanted	as	whole	grafts	into	26	(58%)	pediatric	and	19	(42%)	
adult	recipients.	In	the	other	11	(19%)	cases,	livers	were	split	gen‐
erating	10	LLSs,	10	ERGs,	one	left	and	one	right	 lobes.	Two	(3%)	
pediatric	grafts	were	reduced	on	the	back	table.	 In	4	cases,	split	
liver	procurements	were	performed	in	donors	>50	years.	The	clin‐
ical	characteristics	of	split	liver	donors	<18	and	>50	years	are	sum‐
marized	in	Table	S1.
In	summary,	68	split	liver	procedures	were	performed	after	the	in‐
troduction	of	the	new	SLP,	generating	one	left	lobe,	one	right	lobe,	66	
LLSs	(one	LLS	was	discarded	because	of	vascular	injury),	and	67	ERGs.	
For	outcomes	evaluation,	the	left	and	right	lobes	and	two	ERGs	that	
were	part	of	multiorgan	transplantations	were	excluded,	resulting	in	
66	LLSs	and	65	ERGs	enrolled	in	the	study.	All	LLSs	were	transplanted	
into	 pediatric	 recipients.	 In	 57	 (87.7%)	 cases,	 the	 ERG	 was	 trans‐
planted	into	adults,	and	in	8	(12.3%)	cases	into	a	child	(Table	3).	Two	
children,	with	UNOS	1	status,	received	ERGs	from	donors	>18	years.
The	68	consecutive	split	liver	procedures	chosen	as	the	control	
group	were	performed	between	June	2013	and	August	2015.	In	the	
control	group,	49	(72%)	split	procedures	were	performed	in	donors	
aged	 18‐50	years,	 11	 (16.2%)	 in	 donors	 <18	years,	 and	 8	 (11.8%)	
in	donors	>50	years	 (Table	3).	These	were	standard	split	 liver	pro‐
cedures	 in	66	 (97.1%)	 cases	 and	 full‐left/full‐right	 split	 in	2	 (2.9%)	
cases.	One	LLS	graft	was	not	transplanted	because	of	vascular	 in‐
jury.	 Similar	 to	 the	 study	 group,	 left	 and	 right	 lobes	 and	one	ERG	
used	 for	 combined	 liver‐pancreas	 transplantation	 were	 excluded,	
resulting	in	65	LLSs	and	65	ERGs	enrolled	in	the	study.
The	 clinical	 characteristics	 of	 the	donors	who	underwent	 split	
liver	procurement	in	the	new	and	old	SLP	were	similar	except	for	the	
ITU‐stay,	which	was	longer	in	the	study	period	(3	[0‐19]	vs	2	[0‐11]	
days,	P	=	.039)	(Table	4).
3.2 | Outcomes of SLT
3.2.1 | Left‐lateral segment graft transplantation
Table	5	 shows	 the	 surgical	 and	 recipient	 characteristics	 of	 LLS	
transplantation.	During	 the	 study	 period,	 the	 LLS	 recipients	were	
TA B L E  1  Causes	of	nonsplitting	in	adult	donors	offered	for	split	
liver transplantation
Number (%)
At	the	time	of	donor	offer 171	(85.9)
Donor
Abnormal	LFTs 30	(15.1)
Steatosis	on	US	scan 20	(10.1)
Hemodynamic	instability 20	(10.1)
Hepatic	lesions	on	US	scan 7	(3.5)
Comorbidities 4	(2)
Prolonged	ITU	stay 4	(2)
Recipient
Inadequate	donor/recipient	size	matching 65	(32.7)
No	suitable	recipients	on	the	waiting	list 13	(6.5)
Logistic	issue 8	(4)
At	donor	laparotomy 28	(14.1)
Donor
Steatosis	at	liver	biopsy 6	(3)
Intraoperative	vascular	anomalies 6	(3)
Intraoperative	hemodynamic	instability 4	(2)
Recipient
Inadequate	donor/recipient	size	matching 10	(5)
Intraoperative	logistic	issue 2	(1)
ITU,	 intensive	 therapy	 unit;	 LFTs,	 liver	 function	 tests;	 US	 scan,	 ultra‐
sound	scan.
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significantly	 younger	 compared	 to	 those	 transplanted	 in	 the	 con‐
trol	 period,	 including	 77.3%	 vs	 58.5%	 children	 <24	months	 of	 age	
(P = .025).
The	overall	1‐year	patient	survivals	were	84.8%	and	87.7%	in	the	
study	and	control	period	respectively	 (P	=	.408);	the	overall	1‐year	
graft	survival	was	78.8%	for	the	new	SLP	and	80%	for	the	old	SLP	
(P	=	.610)	(Figure	3).
In	the	study	group,	10	(15.2%)	patients	died	within	1	year	from	
SLT,	of	whom	5	(50%)	were	urgent	SLT.	Of	7	(10.8%)	children	who	
died	during	the	old	SLP,	only	one	(14.2%)	had	urgent	transplantation.	
The	retransplantation	rate	was	similar	in	the	two	groups	(4	[6.1%]	vs	
5	[7.7%]	[P	=	.712])	(Table	6).	The	characteristics	of	the	deceased	and	
retransplanted	LLS	recipients	are	detailed	in	Table	S2.
Within	 the	 first	 year	of	SLT,	postoperative	 technical	 complica‐
tions	were	comparable	in	the	two	periods	(20	[30.3%]	vs	24	[36.9%],	
[P	=	.529])	(Table	S3).
3.2.2 | Extended right graft transplantation
The	 technical	 and	 recipient	 characteristics	 of	 ERG	 transplantation	
were	 comparable	 in	 the	 two	 periods	 (Table	7).	 The	 1‐year	 patient	
survival	was	93.8%	in	both	groups	(P	=	.538),	whereas	1‐year	graft	
survival	was	86.2%	after	the	introduction	of	the	new	SLP	and	83.1%	
in	the	control	period	(P	=	.753)	(Figure	4).
In	 the	 study	group,	4	 (6.2%)	patients	died	within	1	year	of	SLT,	
of	whom	1	(25%)	was	transplanted	with	UNOS	1	status;	of	4	(6.2%)	
deceased	patients	in	the	control	group,	none	received	urgent	trans‐
plantation.	The	retransplantation	rate	was	similar	in	the	two	groups	
(5	[7.7%]	vs	7	[10.8%]	[P	=	.638])	(Table	8).	The	characteristics	of	the	
deceased	and	retransplanted	ERG	recipients	are	reported	in	Table	S4.
Postoperative	complications	were	observed	in	15	(23%)	ERG	re‐
cipients	transplanted	in	the	new	SLP	and	in	24	(36.9%)	cases	in	the	
control	group	(P	=	.085)	(Table	S5).
TA B L E  2  Characteristics	of	donors	offered	for	split	liver	transplantation	under	the	new	split	liver	policy
Variables
Total donor 
offered for SLT
Donor refused for donor 
characteristicsa 
Donor refused for absence of 
suitable recipientsa 
Donors accepted 
for SLT P value
Number	(%) 252 101	(40.1%) 98	(38.9%) 53	(21%) ‐
Age	(years) 41	(18‐50) 43.5	(18‐50) 41	(18‐50) 38	(18‐50) .044
Gender	(female) 88	(34.9%) 38	(37.6%) 29	(29.6%) 21	(39.6%) .366
BMI 25	(16‐46) 25	(18‐46) 26	(18‐46) 24	(18‐32) <.0001
Weight	(kg) 75	(30‐150) 75	(42‐120) 80	(30‐150) 70	(50‐90) <.0001
Height	(cm) 170	(130‐192) 170	(146‐190) 175	(130‐192) 170	(150‐190) .158
Blood	group
0 94	(37.3%) 45	(44.6%) 22	(22.4%) 27	(50.9%)
A 103	(40.9%) 37	(36.7%) 50	(51.0%) 16	(30.2%)
AB 14	(5.6%) 5	(4.9%) 9	(9.2%) 0	(%) .002
B 41	(16.3%) 14	(13.9%) 17	(17.3%) 10	(18.9%)
Use	of	vasopressors	
(yes)
198	(78.6%) 76	(75.2%) 69	(70.4%) 42	(86.8%) <.0001
Use	>1	vasopressors 49	(19.4%) 25	(24.8%) 13	(13.3%) 11	(20.8%) .088
ITU	stay	(days) 3	(0‐37) 2	(0‐37) 3	(0‐16) 3	(0‐19) .648
AST	(U/L) 45	(7‐15285) 55	(9‐15285) 40	(7‐497) 42	(9‐628) .023
ALT	(U/L) 41	(5‐5575) 56	(6‐5575) 32	(5‐971) 34	(9‐530) .035
Total	bilirubin	(mg/dL) 0.4	(0.1‐7.8) 0.4	(0.1‐7.8) 0.4	(0.1‐3.04) 0.3	(0.1‐2.6) .038
GGT	(U/L) 39	(5‐988) 42	(5‐988) 33	(8‐537) 33	(5‐624) .378
Serum	sodium	
(mmL/L)
150	(130‐187) 150	(131‐183) 151	(130‐187) 148	(131‐173) .438
Cause	of	death
Cerebrovascular	
accident
112	(44.4%) 40	(39.6%) 46	(46.9%) 26	(49.1%)
Trauma 93	(36.9%) 38	(37.6%) 37	(37.8%) 18	(34%) .248
Anoxia 38	(15.1%) 20	(19.8%) 12	(12.2%) 6	(11.3%)
Others 9	(3.6%) 3	(3%) 3	(3.1%) 3	(5.7%)
ALT,	alaninoaminotransferase;	AST,	aspartatoaminotransferase;	GGT,	gamma‐glutamyltransferase;	BMI,	body	mass	index;	ITU,	intensive	therapy	unit;	
LFTs,	liver	function	tests;	US	scan,	ultrasound	scan.
aLiver	graft	from	donor	refused	for	SLT	due	to	donor	or	recipient	characteristics	was	used	as	whole	liver	graft.	
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3.2.3 | Univariate and multivariate analysis
By	log‐rank	test,	no	significant	differences	in	1‐year	patient	or	graft	
survivals	for	LLS	and	ERG	transplantations	were	observed,	accord‐
ing	to	the	centers’	split	liver	procurement	volume	(Table	S6).
Among	 LLS	 transplantation,	 re‐transplantation	 vs	 first	 trans‐
plantation	 (HR	=	3.349,	P	=	.006),	 recipient	 body	weight	 >20	kg	 vs	
≤20	kg	 (HR	=	4.088,	P	=	.001),	 and	 donor‐to‐recipient	weight	 ratio	
(DRWR)	≤4	vs	>4	(HR	=	1.380,	P	=	.018)	were	risk	factors	for	graft	
failure	by	univariate	analysis	(Table	S7).	In	the	multivariate	analysis,	
recipient	body	weight	>20	kg	vs	≤20	kg	 (HR	=	5.113,	P = .048) and 
retransplantation	as	an	indication	of	SLT	(HR	=	2.641,	P	=	.035)	were	
predictors	of	graft	failure	(Figures	S1,	S2).
In	 ERG	 transplantation,	 cold	 ischemic	 time	 (CIT)	 >8	hours	 vs	
≤8	hours	 (HR	=	2.574,	 P	=	.039)	 and	 donor	 ITU‐stay	 >5	days	 vs	
≤5	days	 (HR	=	1.946,	 P	=	.046)	 were	 identified	 as	 risk	 factors	 for	
graft	 loss	 according	 to	 the	univariate	 analysis	 (Table	S8),	 and	only	
CIT	>8	hours	vs	≤8	hours	(HR	=	2.475,	P	=	.048)	 in	the	multivariate	
analysis	(Figure	S3).
3.3 | Impact of the new split liver policy on the LT‐
waiting list
Since	the	new	SLP	was	introduced,	the	SLT	rate	increased	from	6%	
to	8.4%	and	a	median	of	2	SLTs/week	were	performed.	Compared	
to	the	old	SLP,	the	same	number	of	SLTs	was	achieved	in	a	shorter	
period	(16.5	months	in	the	new	SLP	vs	26.4	months	in	the	old	SLP).
During	 the	 study	 period,	 114	pediatric	 LTs	were	 performed,	
including	 75	 (65.8%)	 SLTs,	 34	 (29.8%)	 whole	 LTs,	 and	 5	 (4.4%)	
LDLTs.	 During	 the	 control	 period,	 150	 pediatric	 LTs	 were	 per‐
formed,	 including	 74	 (49.3%)	 SLTs,	 51	 (34%)	 whole	 LTs,	 and	 25	
(16.7%)	LDLTs.
After	the	introduction	of	the	new	SLP,	the	total	number	of	chil‐
dren	receiving	a	split	graft	increased	from	49.3%	to	65.8%	(P = .009) 
and	the	LDLT	rate	significantly	reduced	compared	to	the	control	pe‐
riod	(4.4%	vs	16.7%,	P	=	.0016).
The	 median	 time	 on	 the	 LT‐waiting	 list	 reduced	 from	 229	
(10‐2121)	days	to	80	(12‐2503)	days	(P	=	.045).	Child	dropout	from	
the	 LT‐waiting	 list	 decreased	 from	 2.5%	 (5/200)	 to	 1.8%	 (3/163)	
(P	=	.735),	thus	the	pediatric	waiting	list	mortality	was	4.5%	(9/200)	
in	the	old	SLP	and	2.5%	(4/163)	in	the	new	SLP	(P	=	.398).	Of	4	chil‐
dren	awaiting	LT	who	died	in	the	study	period,	2	(50%)	patients	were	
candidates	for	urgent	re‐LT.	After	the	introduction	of	the	new	SLP,	
a	median	of	2	pediatric	 LTs/week	were	performed	 compared	 to	1	
pediatric	LT/week	during	 the	control	period.	Moreover,	during	 the	
study	period,	one	donor	every	2	days	was	offered	for	SLT	to	the	pe‐
diatric	LT‐waiting	list	and	one	split	graft/weekly	was	accepted	for	a	
child	awaiting	LT.
During	 the	 new	 SLP,	 1503	 adult	 LTs	were	 performed,	 including	
1435	(95.5%)	whole	LTs,	60	(4%)	SLTs,	and	8	(0.5%)	LDLTs.	In	the	con‐
trol	period,	2148	LTs	were	carried	out,	including	2069	(96.3%)	whole	
LTs,	61	(2.8%)	SLTs,	and	18	(0.8%)	LDLTs.	After	the	new	SLP	was	ad‐
opted,	 the	 SLT	 rate	 in	 adult	 recipients	 increased	 from	 2.8%	 to	 4%	
(P	=	.058)	and	the	median	time	from	listing	to	LT	remained	stable	(282	
[0‐5951]	vs	299	[0‐5095]	days	during	the	study	and	control	period	re‐
spectively	[P	=	.142]).	Since	the	introduction	of	the	new	SLP,	the	adult	
LT‐waiting	list	mortality	significantly	reduced	from	9.7%	(369/3814)	to	
5.2%	(149/2891)	 (P	<	.001)	and	the	adult	LT‐waiting	 list	dropout	rate	
remained	stable	(7.1%	[204/2891]	vs	6.1%	[232/3814]	in	the	new	and	
old	allocation	programs,	respectively	[P	=	.109]).	During	the	study	pe‐
riod,	a	median	of	24	adult	LTs/week	was	performed,	with	21	adult	LTs/
week	in	the	control	group.
4  | DISCUSSION
Improving	 SLT	 programs	 has	 attracted	 great	 interest	 in	 recent	
years	as	a	method	of	 reducing	pediatric	LT‐waiting	 list	mortality.10 
TA B L E  4  Split	liver	donor	characteristics	under	the	new	and	old	
split	liver	policy
Donor variables
New split 
liver policy
Old split liver 
policy P value
Number 66 65
Age	(years) 36	(5‐66) 33	(8‐58) .836
<18	years 10	(15.4%) 11	(16.7%)
18‐50	years 52	(80%) 46	(70.8%)
>50	years 4	(6.2%) 8	(12.3%)
Gender	(female) 25	(51%) 24	(49%) 1.000
BMI 23	(16‐32) 23	(19‐33) .692
Weight	(kg) 68	(25‐90) 70	(42‐101) .421
Height	(cm) 170 
(125‐190)
170	(145‐194) .245
Blood	group
0 34	(51.5%) 30	(46.2%)
A 22	(33.3%) 30	(46.2%) .211
B 10	(15.2%) 5	(7.7%)
Use	of	vasopressors 45	(66.7%) 35	(53.8%) .155
Use	of	>1	
vasopressors
12	(18.2%) 11	(16.9%) .291
ITU	stay	(days) 3	(0‐19) 2	(0‐11) .039*
AST	(U/L) 40	(9‐628) 42	(8‐357) .639
ALT	(U/L) 29	(9‐530) 34	(8‐269) .978
Total	bilirubin	(mg/dL) 0.5	(0.1‐3) 0.4	(0.1‐8) .078
GGT	(U/L) 30	(5‐624) 28	(5‐545) .712
Serum	sodium	
(mmL/L)
148	(131‐173) 148 
(124‐193)
.363
Cause	of	death
Cerebrovascular 31	(46.9%) 33	(50.8%)
Trauma 24	(36.4%) 21	(32.3%) .632
Anoxia 7	(10.6%) 10	(15.4%)
Others 4	(6.1%) 1	(1.5%)
ALT,	 alaninoaminotransferase;	 AST,	 aspartatoaminotransferase;	 GGT,	
gamma‐glutamyltransferase;	BMI,	body	mass	index;	ITU,	intensive	ther‐
apy	unit.
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Although	the	SLT	rate	constantly	 increased	 in	Europe	 (>400	SLTs/
year	 since	 2002),18	 a	 change	 in	 donor	 demographics	 resulted	 in	 a	
reduction	of	deceased	liver	donors	suitable	for	split	procedures.	The	
main	 issues	 limiting	 the	 expansion	of	 SLT	programs	worldwide	 in‐
clude	(1)	the	need	for	a	national/international	organ	allocation	sys‐
tem	with	an	“intention‐to‐split”	policy,	and	the	cooperation	between	
pediatric	and	adult	LT	centers;	(2)	the	lack	of	international	donor	se‐
lection	criteria	for	SLT;	(3)	split	grafts	have	been	generally	perceived	
by	centers	as	carrying	greater	morbidity	and	mortality	compared	to	
whole	grafts.10,19,20
In	Italy,	the	steady	increase	in	average	age	of	deceased	donors	and	
the	reduction	in	the	number	of	SLTs	causing	a	lengthening	of	waiting	
times	for	pediatric	LT	drove	the	analysis	of	the	Italian	SLT	data21‐27 
and	the	definition	in	2015	of	a	mandatory	SLP,	which	includes	three	
major	 steps:	 first,	 the	 CNT	 offers	 all	 donors	 aged	 18‐50	years	 at	
standard	 risks	 to	 the	 pediatric	 transplant	 centers	 for	 SLT;	 second,	
the	pediatric	transplant	centers	decide	if	the	LLS	is	suitable	for	pedi‐
atric	LT	candidates;	and	third,	the	ERG,	which	is	considered	ab	initio	
fit	 for	 transplantation	 as	 the	pediatric	 donor	 selection	 criteria	 are	
more	narrowing	 than	 those	adopted	 for	adults,	 is	 allocated	 to	 the	
Variables
New split liver policy 
(n = 66)
Old split liver policy 
(n = 65) P value
Surgical	variables
In	situ/ex	situ	split 64	(97%)	/	2	(3%) 63	(96.9%)	/	2	(3.1%) 1.000
Cold	ischemic	time	(hours) 6	(3‐10) 5	(1‐8) .108
Warm	ischemic	time	
(minutes)
47	(24‐110) 40	(30‐121) .238
Recipient variables
Age	(years) 1.1	(0.1‐11.2) 2.1	(0.1‐12.1) .043
Gender	(female) 33	(50%) 36	(55.4%) .601
BMI 16.4	(13	‐23.8) 16.5	(11.3‐22.3) .848
Weight	(kg) 8.7	(4‐35) 12	(6‐30) .020
Height	(cm) 70.1	(53‐135) 84	(58‐152) .014
Blood	group
0 28	(42.4%) 22	(33.8%)
A 23	(34.8%) 33	(50.8%) .271
B 12	(18.2%) 7	(10.8%)
AB 3	(4.5%) 3	(4.6%)
PELD	score 22	(10‐43) 22	(12‐39) 1.000
UNOS	status
1 8	(12.1%) 7	(10.8%)
1B 1	(1.5%) 6	(9.2%)
2A 5	(7.6%) 7	(10.8%) .344
2B 10	(15.2%) 10	(15.4%)
3 42	(63.6%) 35	(53.8%)
Indication for transplantation
Acute	liver	failure 6	(9.1%) 3	(4.6%)
Autoimmune	liver	
disease
2	(3%) 1	(1.5%)
Cholestatic	liver	disease 43	(65.2%) 36	(55.4%)
Tumor 2	(3%) 9	(13.8%) .074
Metabolic	liver	disease 7	(10.6%) 6	(9.2%)
Retransplantation	(early/
late)
4	(2/2)	(6.1%) 10	(1/9)	(15.4%)
Other	disease 2	(3%) ‐
Time	on	waiting	list	to	
transplant	(days)
36	(1‐530) 35	(1‐571) .634
ALT,	alaninoaminotransferase;	AST,	aspartatoaminotransferase;	GGT,	gamma‐glutamyltransferase;	
BMI,	body	mass	 index;	PELD,	pediatric	end‐stage	 liver	disease;	UNOS,	United	Network	of	Organ	
Sharing.
TA B L E  5  Surgical	and	recipient	
characteristics	of	left‐lateral	segment	
transplantation
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best‐matching	adult	recipient.	Subsequently,	the	graft	“splittability”	
remains	only	a	technical	aspect	(ie,	vascular	anomalies).
In	 the	 study	 period,	 donors	 within	 SLT‐criteria	 accounted	 for	
26%	of	all	 liver	donors,	of	which	60%	were	offered	for	SLT	and	of	
these,	21%	were	effectively	used	for	SLT.	Consequently,	the	intro‐
duction	of	 the	new	SLP	 significantly	 increased	 the	number	of	do‐
nors	 offered	 for	 split	 procedures	 and	 SLT	 rate	 represented	 8.4%	
of	all	LT	activity,	which	is	higher	compared	to	the	recent	split	data	
from	the	Eurotransplant	Area	(5%).28	Despite	the	expansion	of	SLT	
donor	criteria,	most	of	the	split	procedures	were	performed	in	young	
donors,	 proving	 that	 pediatric	 centers	 had	 more	 opportunities	 to	
choose	the	best	donor	for	children	candidates	to	LT,	with	high	rate	
of acceptance.29
Among	donors	refused	for	SLT,	40%	were	not	accepted	due	to	
the	 donor	 quality	 and	 39%	due	 to	 the	 absence	 of	 suitable	 recipi‐
ents,	mainly	related	to	donor/recipient	size	matching.	Interestingly,	
the	donors	refused	due	to	the	lack	of	size	matching	recipients	were	
similar	to	those	accepted	for	SLT	for	all	clinical	variables,	except	for	
higher	body	weight.	Therefore,	almost	40%	of	potentially	“splittable”	
donors	are	currently	not	used	for	standard	splitting	procedure,	but	
might	represent	a	consistent	donor	pool	for	full‐right/full‐left	SLT	or	
for	international	networks	of	organ	sharing.20,30
A	mandatory	SLP	has	been	adopted	also	in	other	countries;	thus	
their	split	 liver	donor	selection	criteria	are	much	more	strict	when	
compared	to	 these	currently	used	 in	 Italy.10	 In	United	Kingdom	all	
brain‐death	donors	<40	years,	with	weight	>50	kg,	 and	<5	days	of	
ITU	stay	are	mandatory	offered	for	splitting	in	absence	of	superur‐
gent	or	multivisceral	candidates31;	in	France,	donors	aged	<30	years	
are	 first	 proposed	 to	 pediatric	 LT	 candidates.32	 Contrarily,	 in	 the	
UNOS	network	splitting	is	not	mandatory	and	only	donors	between	
18‐40	years	of	age	with	no	more	than	a	single	vasopressor,	transam‐
inases	≤3	times	normal,	and	body	mass	index	≤28	are	considered	for	
SLT,	but	are	not	primarily	offered	to	pediatric	centers2;	the	result	is	
F I G U R E  3  Patient	(A)	and	graft	(B)	survival	of	left‐lateral	segment	transplantation
TA B L E  6  Causes	of	death	and	retransplantation	after	left‐lateral	
segment	transplantation
Variables
New split 
liver policy 
(n = 66)
Old split liver 
policy (n = 65) P value
Total	number	of	death 10	(15.2%) 7	(10.8%) .456
Cause	of	death
PNF 1	(1.5%) 2	(3.1%) .619
Sepsis 2	(3.0%) 1	(1.5%) .568
MOF 5	(7.6%) 2	(3.1%) .077
Tumor	recurrence 0	(0%) 1	(1.5%) 1.000
Pulmonary	embolism 1	(1.5%) 0	(1.5%) .496
Biliary	complication 0	(0%) 1	(1.5%) 1.000
Cerebrovascular	
accident
1	(1.5%) 0	(0%) .496
Retransplantation 4	(6.1%) 5	(7.7%) .712
Cause	of	retransplantation
PNF/DNF 1	(1.5%) 3	(4.6%) .302
Hepatic	artery	
thrombosis
2	(3%) 0	(0%) .496
Portal	vein	
thrombosis
1	(1.5%) 1	(1.5%) .991
Chronic	rejection 0	(0%) 1	(1.5%) .312
DNF,	delayed	nonfunction;	 LLS,	 left‐lateral	 segment;	MOF,	multiorgan	
failure;	PNF,	primary	nonfunction.
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that	only	6.3%	of	liver	donors	meet	the	SLT	criteria	and	only	3.8%	of	
these	are	utilized	for	SLT.33
Of	the	criteria	used	to	select	donors	suitable	for	split	procedures,	
donor	age	>50	years	and	<10	years	has	been	recognized	as	a	crucial	
risk	factor	for	SLT	graft	failure.18	In	our	series,	donors	aged	>50	years	
were	used	for	SLT	in	only	four	UNOS	1	status	children	because	of	
the	impossibility	of	waiting	longer	for	a	graft;	thus	the	“adapted”	al‐
location	of	ERGs	guaranteed	good	outcomes	in	all	adults.
Notwithstanding	the	promising	results	on	the	use	of	partial	grafts	
from	pediatric	donors,24	 presently	 in	 Italy	 split	 liver	procedures	 in	
donors	<18	years	are	not	mandatory.	However,	our	data	confirmed	
that	SLTs	from	young	donors	have	favorable	outcomes,34	suggesting	
that	split	procedures	should	be	mandatory	also	in	pediatric	donors	
(at	least	for	body	weight	>40	kg),	limiting	the	use	of	reduced	grafts	
to selected cases.
Our	experience	showed	that	the	presence	of	a	national	organ‐
exchange	organization	and	the	collaboration	between	pediatric	and	
adult	centers	were	key	factors	to	maximize	the	use	of	donors	without	
compromising	outcomes.19,35‐37	The	availability	of	surgeons	trained	
to	perform	split	procedures	in	most	of	the	Italian	transplant	centers	
TA B L E  7  Surgical	and	recipient	 characteristics	of	extended	right	graft	transplantation
Variables
New split liver policy 
(n = 65)
Old split liver policy 
(n = 65) P value
Surgical	variables
In	situ/ex	situ	split 58	(89.2%)/7	(10.8%) 59	(90.8%)/6	(9.2%) .778
Cold	ischemic	time	(hours) 7	(4‐11) 6	(3‐15) .125
Warm	ischemic	time	(minutes) 42	(22‐165) 35	(22‐80) .207
Recipient variables
Age	(years) 53	(2‐71) 53	(8‐69) .714
Gender	(female) 29	(44.6%) 38	(58.5%) .160
BMI 23.2	(13.4‐32) 23.5	(14.3‐43.3) .257
Weight	(kg) 64	(11‐103) 65	(22‐109) .782
Height	(cm) 168	(88‐183) 165	(86‐180) .279
Blood	group
0 30	(46.2%) 21	(32.3%)
A 22	(33.8%) 37	(56.1%)
B 12	(18.5%) 6	(9.2%) .040
AB 1	(1.5%) 1	(1.5%)
Biochemical	MELD/PELD 18	(10‐35) 20	(9‐42) 1.000
UNOS	status
1 2	(3.1%) 3	(4.6%)
2A 5	(7.7%) 8	(12.3%) .824
2B 38	(58.5%) 35	(53.8%)
3 20	(30.8%) 19	(29.2%)
Indication	for	SLT
Alcoholic	liver	disease 10	(15.4%) 8	(12.3%)
Autoimmune	liver	disease 12	(18.5%) 9	(13.8%)
Cholestatic	liver	disease 4	(6.2%) 2	(3.1%)
Tumor 16	(24.6%) 24	(36.9%) .109
Viral‐related	cirrhosis 16	(24.6%) 7	(10.8%)
Cryptogenic	cirrhosis 1	(1.5%) 5	(7.7%)
Metabolic	liver	disease 5	(7.7%) 4	(6.2%)
Retransplantation 0	(0%) 1	(1.5%)
Others 1	(1.5%) 5	(7.7%)
Time	on	waiting	list	to	
transplant	(days)
91	(1‐1682) 74	(1‐1479) .764
ALT,	alaninoaminotransferase;	AST,	aspartatoaminotransferase;	GGT,	gamma‐glutamyltransferase;	
BMI,	body	mass	index;	MELD,	model	for	end‐stage	liver	disease;	LFTs,	 liver	function	tests;	PELD,	
pediatric	end‐stage	liver	disease;	UNOS,	United	Network	of	Organ	Sharing.
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was	also	essential	to	implement	the	national	SLT	programme.20	The	
standardization	 of	 surgical	 techniques,	 consisting	 of	 in	 situ	 split	
procedures38	and	rules	for	vascular	structures’	division,	resulted	in	
limited	CIT	(organs	were	shipped	from	the	donor	hospital	to	the	re‐
cipient	center)	and	low	rates	of	vascular	complications,	which	repre‐
sent	the	most	common	issues	in	SLT.8,28,39‐41	These	good	outcomes	
justify	the	enormous	logistical	efforts	of	the	in	situ	split	technique	
related	to	the	prolonged	donor	surgery42;	hence,	a	previous	Italian	
experience	reported	that	standard	in	situ	split	procurement	added	
156	±	33	minutes	to	the	donor	operation,	whereas	using	full‐right/
full‐left	split	procedure	required	185	±	50	more	minutes.27
The	introduction	of	the	new	SLP	did	not	have	an	impact	on	SLT	
morbidity	and	mortality,	which	were	comparable	to	the	control	pe‐
riod.	Children	transplanted	with	LLS	showed	1‐year	patient	survival	
of	85%	and	graft	 survival	 of	79%,	 in	 line	with	 the	European	Liver	
Transplant	Registry18	(patient	survival:	89.1%;	graft	survival:	83.3%)	
and	UNOS43	data	(graft	survival:	75.5%).	Adults	receiving	ERG	had	
a	1‐year	patient	survival	of	94%	and	a	graft	survival	of	86%,	similar	
to	those	reported	in	literature.8
In	 children	 receiving	LLS,	 retransplantation	and	 recipient	body	
weight	>20	kg	were	the	only	risk	factors	of	graft	failure,	confirming	
that	the	recipient	status	significantly	 influences	SLT	outcomes	and	
adequate	donor/recipient	size	matching	is	essential	to	avoid	“small‐
for‐size	syndrome.”44	 In	ERG	transplantation,	only	CIT	>8	hours	in‐
creased	the	risk	of	graft	failure	in	agreement	with	the	UNOS	data.43
After	the	new	SLP,	the	number	of	liver	offers	to	LT	pediatric	can‐
didates	 significantly	 improved	 (proportionally	 to	 the	 Italian	 donation	
rate),	giving	more	opportunities	 to	children	 to	 receive	SLT;	 in	conse‐
quence	the	median	pediatric	LT‐waiting	list	time	significantly	decreased	
(from	 7	months	 to	 less	 than	 3	months),	 being	 considerably	 shorter	
compared	to	other	series	(ie,	in	the	US	>40%	of	children	spend	over	a	
year	on	the	waiting	list).45	Likewise,	the	pediatric	LT‐waiting	list	mor‐
tality	 rate	 was	 2.5%,	 remarkably	 lower	 compared	 to	 other	 reports	
(7‐12%),1,2,10	and	in	half	of	the	cases	death	occurred	in	children	awaiting	
urgent	re‐LT.	Because	in	Italy	the	majority	of	children	are	transplanted	
F I G U R E  4  Patient	(A)	and	graft	(B)	survival	of	extended	right	graft	transplantation
TA B L E  8  Causes	of	death	and	retransplantation	after	extended	
right	graft	transplantation
Variables
New split liver 
policy (n = 65)
Old split liver 
policy (n = 65) P value
Total	number	of	
death
4	(6.2%) 4	(6.2%) 1.000
Cause	of	death
Sepsis 2	(3.1%) 1	(1.5%) .559
Myocardial	
infarction
1	(1.5%) 0	(0%) .315
Tumor	recurrence 1	(1.5%) 1	(1.5%) 1.000
MOF 0	(0%) 2	(3%) .496
Retransplantation 5	(7.7%) 7	(10.8%) .638
Cause	of	retransplantation
PNF/DNF 3	(4.6%) 3	(4.6%) 1.000
Hepatic	artery	
thrombosis
2	(3.1%) 2	(3.1%) 1.000
Biliary	
complications
0	(0%) 2	(3.1%) .154
DNF,	delayed	nonfunction;	ERG,	extended	right	graft;	MOF,	multiorgan	
failure;	PNF,	primary	nonfunction.
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with	split	grafts	from	deceased	donors,	we	believe	that	the	low	pedi‐
atric	LT‐waiting	list	mortality	is	mainly	related	to	the	pediatric	priority	
in	organ	allocation.	Additionally,	in	the	observational	period	the	LDLT	
activity	reduced,	thus	the	paucity	of	cases	and	the	different	centers’	
policy	on	the	use	of	 living‐related	resource	do	not	allow	to	 interpret	
data.	Hence,	the	SLT	rate	is	influenced	not	only	by	the	adoption	of	man‐
datory‐SLP	and	donation	rate	but	also	by	the	pediatric	LT‐waiting	list	
demand	(which	is	variable	over	the	time)	and	the	use	of	LDLT	resource.
On	the	adult	side,	the	prioritization	of	UNOS	1	status	and	MELD	
≥30	 LT	 candidates	 ensured	 that	 the	 mandatory‐SLP	 did	 not	 have	 a	
negative	impact	on	the	adult	LT‐waiting	list	mortality	and	dropout	rate.	
The	decreased	adult	LT‐waiting	list	mortality	rate	observed	in	the	study	
period	was	not	related	to	the	new	SLP,	but	it	was	caused	by	the	higher	
number	of	adult	LT	performed	and	the	introduction	of	the	new	liver	al‐
location	model	(MELD/ISO	score),	which	includes	MELD	exception	and	
hepatocellular	carcinoma	priorization.14	 In	 the	current	 system,	 trans‐
plant	centers	accepting	ERG	could	choose	the	adult	recipient	based	not	
only	on	the	MELD/ISO	score	but	also	on	the	recipient	clinical	status	and	
the	donor/recipient	size	matching,	resulting	in	an	increased	rate	of	par‐
tial	grafts	accepted	for	adults.	Moreover,	the	presence	of	urgent/MELD	
≥30	adult	candidates	eliminates	the	obligation	of	splitting	but	does	not	
prohibit	the	possibility	for	those	to	receive	a	SLT	(as	occurred	in	2	cases	
in	our	study).	ERGs	were	allocated	to	a	relatively	low	biochemical	MELD	
score	(18	[10‐35]),	being	in	line	with	other	series.46	Limitations	of	our	
study	consist	in	matching	the	new	SLP	with	an	historical	control	group	
and	to	not	compare	ERG	with	whole	graft;	thus,	similar	10‐years	out‐
comes	of	ERG	and	whole	LT	performed	in	Italy	were	recently	reported.9
In	conclusion,	 the	current	 is	 the	first	 report	of	a	national	man‐
datory	SLP.	The	first	donor	offer	to	pediatric	LT	candidate	increases	
the	number	of	children	receiving	SLT,	resulting	in	low	LT‐waiting	list	
dropout	and	mortality	rate,	which	is	mainly	limited	to	urgent	trans‐
plantation.	The	prioritization	of	organ	allocation	to	UNOS	1	status	
and	MELD	≥30	adult	 candidates	 ensure	 that	mandatory	SLP	does	
not	harm	 the	adult	 LT‐waiting	 list.	 Split	 liver	donor	 criteria	 can	be	
safely	expanded,	providing	optimal	graft	and	patient	SLT	outcomes.	
Thus,	 a	 significant	 proportion	 of	 potentially	 “splittable”	 donors	 is	
currently	not	used	 for	 conventional	 split	 procedures	but	might	be	
employed	for	adult‐to‐adult	SLT	or	for	international	organ	networks	
in	order	to	optimize	liver	allograft	resources.
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